CYNTHIA SEIGEL: Open Payments
NPI 1740467539 · MISHAWAKA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,153 in 64 payments from 16 companies in 2025. Trend: 2023 $743 · 2024 $1,359 · 2025 $1,153
Food & beverage: $1,078Education: $75
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $183 |
| Novartis Pharmaceuticals Corporation | 10 | $179 |
| Galderma Laboratories, L.P. | 8 | $154 |
| UCB, Inc. | 4 | $98 |
| Incyte Corporation | 3 | $85 |
| LEO Pharma Inc. | 3 | $76 |
| ABBVIE INC. | 4 | $73 |
| GENZYME CORPORATION | 3 | $56 |
| E.R. Squibb & Sons, L.L.C. | 3 | $52 |
| Amgen Inc. | 2 | $39 |
Products named: TREMFYA, NEMLUVIO, COSENTYX, Bimzelx, OPZELURA, DUPIXENT, RINVOQ, Sotyktu.
Industry payments across IN — which companies pay providers there.
